CMS Finalizes Medicaid Prescription Drug Rule – On January 21, 2016, CMS finalized a rule detailing reforms to the rebate and reimbursement systems for Medicaid prescription drugs, which the agency estimates “will save federal and state governments an estimated $2.7 billion over five years.”  According to CMS, the rule establishes the long term framework for implementation of the Medicaid drug rebate and reimbursement programs, and the rule will also “close loopholes, incentivize pharmacies to utilize generic drugs by ensuring proper reimbursements for their cost, and give territories additional tools to manage Medicaid drug costs.”  A copy of the final rule is available here.  CMS’s press release announcing the rule is available here.

Save The Date: 25th Annual Health Law & Policy Forum
King and Spalding’s 25th annual Health Law & Policy Forum will take place in Atlanta on March 21, 2016 at the St. Regis Hotel in Buckhead.  We are pleased to present keynote speaker Bob Woodward of The Washington Post to share his insights on the politics affecting national health policy.  To pre-register, please click here.